First Trust Health Care AlphaDEX® Fund (FXH)
Investment Objective/Strategy - The First Trust Health Care AlphaDEX® Fund is an exchange-traded fund. The investment objective of the Fund is to seek investment results that correspond generally to the price and yield, before fees and expenses, of an equity index called the StrataQuant® Health Care Index.
There can be no assurance that the Fund's investment objectives will be achieved.
  • The StrataQuant® Health Care Index is an "enhanced" index developed, maintained and sponsored by ICE Data Indices, LLC or its affiliates ("IDI") which employs the AlphaDEX® stock selection methodology to select stocks from the Russell 1000® Index.
  • IDI constructs the StrataQuant® Health Care Index by ranking the stocks which are members of the Russell 1000® Index on growth factors including three, six and 12-month price appreciation, sales to price and one year sales growth, and, separately, on value factors including book value to price, cash flow to price and return on assets. All stocks are ranked on the sum of ranks for the growth factors and, separately, all stocks are ranked on the sum of ranks for the value factors.
  • Each stock receives either its growth or value score rank as its selection score based on its style designation as determined by Russell. Stocks which Russell allocates between both growth and value receive the better of their growth or value score rank as their selection score.
  • IDI then ranks those stocks contained in the health care sector according to their score. The greater of the top 75% of the eligible universe or 40 stocks is selected for the StrataQuant® Health Care Index.
    • If the total count of eligible stocks in the health care sector falls below 40, all eligible stocks will be included.
  • The selected stocks are divided into quintiles based on their rankings and the top ranked quintiles receive a higher weight within the index. The stocks are equally-weighted within each quintile.
  • The index is reconstituted and rebalanced quarterly.
Fund Overview
Fund TypeHealth Care
Investment AdvisorFirst Trust Advisors L.P.
Investor Servicing AgentBank of New York Mellon Corp
Fiscal Year-End07/31
ExchangeNYSE Arca
Inception Price$20.00
Inception NAV$20.00
Rebalance FrequencyQuarterly
Gross Expense Ratio*0.61%
Net Expense Ratio*0.61%
* As of 12/1/2021
Expenses are capped contractually at 0.70% per year, at least until November 30, 2022. Please see the Fees and Expenses of the Fund section in the fund’s prospectus for more details.
Current Fund Data (as of 5/13/2022)
Closing NAV1$105.19
Closing Market Price2$105.15
Bid/Ask Midpoint$105.17
Bid/Ask Discount0.02%
30-Day Median Bid/Ask Spread30.08%
Total Net Assets$1,393,787,881
Outstanding Shares13,250,002
Daily Volume149,153
Average 30-Day Daily Volume80,720
Closing Market Price 52-Week High/Low$128.11 / $101.87
Closing NAV 52-Week High/Low$128.05 / $101.90
Number of Holdings (excluding cash)85
NAV History (Since Inception)
Past performance is not indicative of future results.
Distribution Information
30-Day SEC Yield (as of 4/29/2022)40.37%
Unsubsidized 30-Day SEC Yield (as of 4/29/2022)50.37%
Index Yield (as of 4/29/2022)60.98%
Fund Characteristics (as of 4/29/2022)7
Maximum Market Cap.$477,503
Median Market Cap.$18,400
Minimum Market Cap.$4,041
Price/Cash Flow13.39
Top Holdings (as of 5/13/2022)*
Holding Percent
Gilead Sciences, Inc. 2.24%
Premier, Inc. (Class A) 2.20%
United Therapeutics Corporation 2.18%
Viatris Inc. 2.17%
Hologic, Inc. 2.12%
Quest Diagnostics Incorporated 2.12%
Pfizer Inc. 2.05%
UnitedHealth Group Incorporated 2.03%
AbbVie Inc. 2.02%
Vertex Pharmaceuticals Incorporated 2.01%

* Excluding cash.  Holdings are subject to change.

Bid/Ask Premium/Discount (as of 5/13/2022)
  2021 Q1 2022 Q2 2022 Q3 2022
Days Traded at Premium 127 16 22 ---
Days Traded at Discount 125 46 8 ---
Top Industry Exposure (as of 5/13/2022)
Medical Equipment and Services 38.86%
Pharmaceuticals and Biotechnology 38.46%
Health Care Providers 22.68%
Hypothetical Growth of $10,000 Since Inception (as of 5/13/2022) *